Results 241 to 250 of about 2,974,682 (398)
Covalent Binding of the Boronic Acid-Based Inhibitor GSK4394835A to Phosphodiesterase 3B, a Drug Target for Cardiovascular Disease. [PDF]
Eaton SA, Christianson DW.
europepmc +1 more source
Pathogenesis and Therapeutics for Chronic Pruritus of Unknown Origin: A Systematic Review
ABSTRACT Chronic pruritus of unknown origin (CPUO) is a distressing condition characterized by persistent itch lasting over 6 weeks without an identifiable cause. The underlying mechanisms remain poorly understood, complicating diagnosis and treatment.
Yagiz Matthew Akiska +8 more
wiley +1 more source
Exploring Patient Pathways and Care Situations in Men With Erectile Dysfunction in Different PDE-5 Inhibitor Regulatory Settings. [PDF]
May U, Werthner Q, Weigmann H, Bauer C.
europepmc +1 more source
Elevated Salivary Theobromine and Long‐Term Improvement of Periodontal Health in Two Cohort Studies
ABSTRACT Background Theobromine, a methylxanthine mainly found in chocolate, has been suggested to possess various health‐promoting properties. This study aimed to investigate the long‐term effect of salivary theobromine levels on periodontitis severity using 7‐ and 10‐year follow‐up data from the prospective Studies of Health in Pomerania (SHIP‐TREND ...
Thomas Kocher +8 more
wiley +1 more source
Gaurav Gulati, Michael S. Kiernan
doaj +1 more source
Phosphodiesterase-4 inhibition in localized scleroderma: A case series of topical roflumilast. [PDF]
Barnawi G +4 more
europepmc +1 more source
Effect of phosphodiesterase inhibitor on diabetic nephropathy. [PDF]
Kang SW.
europepmc +1 more source

